While targeted therapies are generally more specific than traditional chemotherapy, they are not without side effects. For instance, inhibiting VEGF can lead to hypertension and increased risk of bleeding, while targeting HER2 can cause cardiac issues. Continuous monitoring and managing these side effects are crucial for patient care.
